Hybrid eventIn-person & virtual
June 24–26, 2027Rome, Italy

Talk Details · Traditional Medicine 2026

Akkermansia muciniphila 001 (AKK001™) postbiotic for body morphology and metabolic indicators in an overweight population: A randomized, controlled trial

Keynote · Virtual · Day 2

Abstract

About this talk

A 90-day randomized, placebo-controlled intervention study was conducted to examine the differences in body morphology, metabolic indicators, liver and kidney function and thyroid function of 60 overweight and obese people after 1 month and 3 months of intervention with one capsule daily containing 1.5 × 10¹ TFU pasteurized Akkermansia muciniphila 001 postbiotic (AKK001™) and an undisclosed amount of amount of butyrate (tributyrin), compared with the placebo-control group. Results were that one and three months after intervention, the intervention group showed statistically significant differences (P<0.05) compared to the control group in weight, body fat percentage, BMI, waist circumference, hip circumference, abdominal subcutaneous fat thickness, abdominal visceral fat thickness, glucose, total cholesterol, triglycerides, HDL-cholesterol, LDL- cholesterol, and insulin, as well as ALT, AST, total bilirubin, creatinine and urea nitrogen, thyroid-stimulating hormone, free triiodothyronine and free thyroxine. In conclusion, a pasteurized Akkermansia muciniphila 001 postbiotic product was effective for improving anthropometric measures, body morphology, metabolic indicators as well as liver, kidney and thyroid function.

Speaker

About the speaker

Gene Bruno

Gene Bruno

Nutraland, United States

View full speaker profile →

Join the Traditional Medicine 2027 delegation

Rome · June 24–26, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us